Personalized Patient and Caregiver Education After Stroke (MyStroke)

October 25, 2023 updated by: Christopher Favilla, University of Pennsylvania
This is a randomized pilot trial to evaluate the impact of a customizable stroke education app (vs standard of care discharge education) on patient satisfaction and education retention. The impact of the intervention will be assessed 7, 30, and 90 days post-discharge.

Study Overview

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Hospital of the University of Pennsylvania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Admitted for ischemic stroke
  • At least 18 years old
  • Patient or caregiver has access to a smart phone, tablet or computer
  • Being discharged to either home or acute rehab

Exclusion Criteria:

  • Patient or caregivers unable or unwilling to access the customized app with a smartphone, tablet, or computer
  • Being discharged to a skilled nursing facility
  • moderate-to-severe aphasia at the time of enrollment (as per NIHSS scoring) if patient is being enrolled without a caregiver

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Customized education app
A customized URL-based platform will present brief education videos addressing a patients stroke etiology, risk factors, stroke prevention medications, and post-stroke lifestyle issues. This URL will be made available to the patient and caregiver.
Half of subjects will receive access to a customized app that will include brief educational videos that have been selected for each patient based on their medical history. These videos will address stroke etiology, underlying risk factors, and stroke prevention medications.
Placebo Comparator: Standard of care discharge education
Standard discharge education is performed by the bedside nurse at the time of hospital discharge.
Half of subjects will be randomized to receive typical discharge education, per the institutional guidelines for standard of care education for stroke patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction survey
Time Frame: Day 90
Likert-style survey assessing patient satisfaction and perception of the stroke education they received.
Day 90
Stroke Patient Education Retention (SPER) survey
Time Frame: Day 90
Validated measure of stroke patient education as it pertains to their stroke etiology and risk factors with scores of 0-10
Day 90
Stroke etiology awareness
Time Frame: Day 90
accurate knowledge of stroke etiology (0=incorrect; 1=correct)
Day 90
EuroQOL-VAS
Time Frame: Day 90
validated quality of life metric, with scores of 0-100
Day 90

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stroke risk factor awareness, 90 days
Time Frame: Day 90
accurate knowledge of stroke risk factors (0=incorrect; 1=correct)
Day 90
Stroke risk factor awareness, 30 days
Time Frame: Day 30
accurate knowledge of stroke risk factors (0=incorrect; 1=correct)
Day 30
Stroke risk factor awareness. 7 days
Time Frame: Day 7
accurate knowledge of stroke risk factors (0=incorrect; 1=correct)
Day 7
Stroke prevention med awareness, 90 days
Time Frame: Day 90
accurate knowledge of stroke prevention medications (0=incorrect; 1=correct)
Day 90
Stroke prevention med awareness, 30 days
Time Frame: Day 30
accurate knowledge of stroke prevention medications (0=incorrect; 1=correct)
Day 30
Stroke prevention med awareness, 7 days
Time Frame: Day 7
accurate knowledge of stroke prevention medications (0=incorrect; 1=correct)
Day 7
Patient satisfaction, 30 days
Time Frame: Day 30
Likert-style survey assessing patient satisfaction and perception of the stroke education
Day 30
Patient satisfaction, 7 days
Time Frame: Day 7
Likert-style survey assessing patient satisfaction and perception of the stroke education
Day 7
SPER, 7 days
Time Frame: Day 7
Stroke Patient Education Retention (SPER) survey
Day 7
SPER, 30 days
Time Frame: Day 30
Stroke Patient Education Retention (SPER) survey
Day 30
Stroke etiology awareness
Time Frame: Day 7
accurate knowledge of stroke etiology (0=incorrect; 1=correct)
Day 7
Stroke etiology awareness
Time Frame: Day 30
accurate knowledge of stroke etiology (0=incorrect; 1=correct)
Day 30

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christopher Favilla, M.D., University of Pennsylvania

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 20, 2021

Primary Completion (Actual)

April 2, 2023

Study Completion (Actual)

April 2, 2023

Study Registration Dates

First Submitted

October 12, 2021

First Submitted That Met QC Criteria

November 1, 2021

First Posted (Actual)

November 12, 2021

Study Record Updates

Last Update Posted (Actual)

October 26, 2023

Last Update Submitted That Met QC Criteria

October 25, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Customized education

Subscribe